According to filings with the U.S. Securities and Exchange Commission, Epic Sciences is raising $24,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Lloyd Sanders played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Epic Sciences
Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine. We are cancer-fighting pioneers, guided by an epic purpose. At Epic Sciences, we constantly strive to push the boundaries of medical technology, finding vital answers to personalize and transform human health. Our people – talented, dedicated, and passionate about their vision – make the difference. We are a culture of collaboration. Working (and playing) as a team empowers us to bring an irrepressible energy to everything we do. It’s challenging, but never dull.

To learn more about Epic Sciences, visit http://www.epicsciences.com/

Contact:
Lloyd Sanders, Chief Executive Officer
858-356-6610

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.